Serum screening with Down's syndrome markers to predict pre-eclampsia and small for gestational age: systematic review and meta-analysis.

[1]  Bert Aertgeerts,et al.  Guidelines for conducting systematic reviews of studies evaluating the accuracy of diagnostic tests , 2009 .

[2]  Philipp Dahm,et al.  Evidence-Based Surgery Chirurgie factuelle Users ’ guides to the surgical literature : how to use an article about a diagnostic test , 2001 .

[3]  Patrick M Bossuyt,et al.  We should not pool diagnostic likelihood ratios in systematic reviews , 2008, Statistics in medicine.

[4]  B. Vohr.  Motor and Cognitive Outcomes in Nondisabled Low-Birth-Weight Adolescents: Early Determinants , 2008 .

[5]  L. Stewart,et al.  Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data , 2007, The Lancet.

[6]  J. Kleijnen,et al.  The value of predicting restriction of fetal growth and compromise of its wellbeing: Systematic quantitative overviews (meta-analysis) of test accuracy literature , 2007 .

[7]  P. Antsaklis,et al.  Screening for pre‐eclampsia and fetal growth restriction by uterine artery Doppler and PAPP‐A at 11–14 weeks' gestation , 2007, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[8]  J. Schwartz,et al.  Evaluating diagnostic tests , 1986, Journal of General Internal Medicine.

[9]  A. Seidler,et al.  Antiplatelet agents for preventing pre-eclampsia and its complications. , 2007, The Cochrane database of systematic reviews.

[10]  A. Herbst,et al.  Perinatal Factors Associated With Cerebral Palsy in Children Born in Sweden , 2006, Obstetrics and gynecology.

[11]  G. ter Riet,et al.  Prediction of pre-eclampsia: a protocol for systematic reviews of test accuracy , 2006, BMC pregnancy and childbirth.

[12]  G. Macones,et al.  Evaluating the thresholds of abnormal second trimester multiple marker screening tests associated with intra-uterine growth restriction. , 2006, American journal of perinatology.

[13]  D. Towner,et al.  Obstetric outcomes in women with elevated maternal serum human chorionic gonadotropin. , 2006, American journal of obstetrics and gynecology.

[14]  N. Wald,et al.  Screening in early pregnancy for pre‐eclampsia using down syndrome quadruple test markers , 2006, Prenatal diagnosis.

[15]  K. Nicolaides,et al.  Prediction of pre‐eclampsia by uterine artery Doppler ultrasonography and maternal serum pregnancy‐associated plasma protein‐A, free β‐human chorionic gonadotropin, activin A and inhibin A at 22 + 0 to 24 + 6 weeks' gestation , 2006, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[16]  Johannes B Reitsma,et al.  Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies , 2006, BMC medical research methodology.

[17]  Johannes B Reitsma,et al.  Evidence of bias and variation in diagnostic accuracy studies , 2006, Canadian Medical Association Journal.

[18]  J. Roiz-Hernández,et al.  Human chorionic gonadotropin levels between 16 and 21 weeks of pregnancy and prediction of pre‐eclampsia , 2006, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[19]  J. Pell,et al.  Pregnancy-Associated Plasma Protein A and Alpha-fetoprotein and Prediction of Adverse Perinatal Outcome , 2006, Obstetrics and gynecology.

[20]  A. Basgul,et al.  The efficacy of first-trimester PAPP-A and free βhCG levels for predicting adverse pregnancy outcome , 2006, Journal of perinatal medicine.

[21]  Johannes B Reitsma,et al.  Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. , 2005, Journal of clinical epidemiology.

[22]  K. Nicolaides,et al.  Prediction of pregnancy complications by first‐trimester maternal serum PAPP‐A and free β‐hCG and with second‐trimester uterine artery Doppler , 2005, Prenatal diagnosis.

[23]  F. Malone,et al.  Quad Screen as a Predictor of Adverse Pregnancy Outcome , 2005, Obstetrics and gynecology.

[24]  J. Harding,et al.  Customised birthweight centiles predict SGA pregnancies with perinatal morbidity , 2005, BJOG : an international journal of obstetrics and gynaecology.

[25]  T. Pekin,et al.  Screening for pre‐eclampsia by using maternal serum inhibin A, activin A, human chorionic gonadotropin, unconjugated estriol, and alpha‐fetoprotein levels and uterine artery Doppler in the second trimester of pregnancy , 2005, The Australian & New Zealand journal of obstetrics & gynaecology.

[26]  Penny Whiting,et al.  Bmc Medical Research Methodology Open Access No Role for Quality Scores in Systematic Reviews of Diagnostic Accuracy Studies , 2005 .

[27]  S. Sritippayawan,et al.  Adverse pregnancy outcomes after a false-positive second trimester serum screen for Down syndrome in Thai pregnant women. , 2005, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[28]  J. Bethel,et al.  Correlation of abnormal second trimester maternal serum alpha-fetoprotein (MSAFP) levels and adverse pregnancy outcome , 2005, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.

[29]  J. Kingdom,et al.  Mid-Trimester Placentation Assessment in High-Risk Pregnancies Using Maternal Serum Screening and Uterine Artery Doppler , 2005, Hypertension in pregnancy.

[30]  P. Bossuyt,et al.  World Health Organization systematic review of screening tests for preeclampsia. , 2005, Obstetrics and gynecology.

[31]  R. Frydman,et al.  Prediction of Preeclampsia or Intrauterine Growth Restriction by Second Trimester Serum Screening and Uterine Doppler Velocimetry , 2004, Fetal Diagnosis and Therapy.

[32]  M. Lindheimer,et al.  World Health Organization Systematic Review of Screening Tests for Preeclampsia , 2004, Obstetrics and gynecology.

[33]  S. Ristić,et al.  Elevated Second-Trimester Free β-hCG as an Isolated Finding and Pregnancy Outcomes , 2004, Fetal Diagnosis and Therapy.

[34]  D. Barker.  The developmental origins of chronic adult disease , 2004, Acta paediatrica (Oslo, Norway : 1992). Supplement.

[35]  E. Thom,et al.  Association of extreme first-trimester free human chorionic gonadotropin-beta, pregnancy-associated plasma protein A, and nuchal translucency with intrauterine growth restriction and other adverse pregnancy outcomes. , 2004, American journal of obstetrics and gynecology.

[36]  F. Malone,et al.  First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial). , 2004, American journal of obstetrics and gynecology.

[37]  D. Altman,et al.  Diagnostic tests 4: likelihood ratios , 2004, BMJ : British Medical Journal.

[38]  P. Bossuyt,et al.  Development and validation of methods for assessing the quality of diagnostic accuracy studies. , 2004, Health technology assessment.

[39]  P. Bossuyt,et al.  Sources of Variation and Bias in Studies of Diagnostic Accuracy , 2004, Annals of Internal Medicine.

[40]  H. Beydoun,et al.  Predicting neonatal outcomes: birthweight, body mass index or ponderal index? , 2004, Journal of perinatal medicine.

[41]  E. Steegers,et al.  First trimester inhibin‐A concentrations and later development of preeclampsia , 2004, Acta obstetricia et gynecologica Scandinavica.

[42]  K. Spencer,et al.  Predicting complications of pregnancy with first‐trimester maternal serum free‐βhCG, PAPP‐A and inhibin‐A , 2003, Prenatal diagnosis.

[43]  Jonathan M Morris,et al.  Association between first trimester maternal serum pregnancy associated plasma protein‐A and adverse pregnancy outcome , 2003 .

[44]  P. Bossuyt,et al.  BMC Medical Research Methodology , 2002 .

[45]  R. Snijders,et al.  First-trimester screening for trisomies 21 and 18 , 2003 .

[46]  D. Kalafatić,et al.  Second trimester total human chorionic gonadotropin, alpha-fetoprotein and unconjugated estriol in predicting pregnancy complications other than fetal aneuploidy. , 2003, European journal of obstetrics, gynecology, and reproductive biology.

[47]  L. Endres,et al.  Isolated low second-trimester maternal serum beta-human chorionic gonadotropin is not associated with adverse pregnancy outcome. , 2003, American journal of obstetrics and gynecology.

[48]  Tianhua Huang,et al.  The Implications of a False Positive Second‐Trimester Serum Screen for Down Syndrome , 2003, Obstetrics and gynecology.

[49]  Tianhua Huang,et al.  Association between second-trimester isolated high maternal serum maternal serum human chorionic gonadotropin levels and obstetric complications in singleton and twin pregnancies. , 2003, American journal of obstetrics and gynecology.

[50]  How-Ran Guo,et al.  Placental sonolucency and pregnancy outcome in women with elevated second trimester serum alpha-fetoprotein levels. , 2003, Journal of the Formosan Medical Association = Taiwan yi zhi.

[51]  K. Leveno,et al.  Inhibin‐A and Superimposed Preeclampsia in Women With Chronic Hypertension , 2003, Obstetrics and gynecology.

[52]  F. Petraglia,et al.  The addition of activin A and inhibin A measurement to uterine artery Doppler velocimetry to improve the early prediction of pre‐eclampsia , 2003, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[53]  David Moher,et al.  The STARD Statement for Reporting Studies of Diagnostic Accuracy: Explanation and Elaboration , 2003, Annals of Internal Medicine [serial online].

[54]  David Moher,et al.  Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Standards for Reporting of Diagnostic Accuracy. , 2003, Clinical chemistry.

[55]  D. Landau,et al.  Elevated maternal mid‐trimester chorionic gonadotropin ≥4 MoM is associated with fetal cerebral blood flow redistribution , 2003, Acta obstetricia et gynecologica Scandinavica.

[56]  David Moher,et al.  Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD Initiative. , 2003, Radiology.

[57]  D. Rennie,et al.  The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. , 2003, Annals of internal medicine.

[58]  Lucas M. Bachmann,et al.  Research Paper: Identifying Diagnostic Studies in MEDLINE: Reducing the Number Needed to Read , 2002, J. Am. Medical Informatics Assoc..

[59]  A. Orr-Urtreger,et al.  First Trimester Maternal Serum Free Human Chorionic Gonadotropin as a Predictor of Adverse Pregnancy Outcome , 2002, Fetal Diagnosis and Therapy.

[60]  Tianhua Huang,et al.  Double-positive maternal serum screening results for down syndrome and open neural tube defects: An indicator for fetal structural or chromosomal abnormalities and adverse obstetric outcomes. , 2002, American journal of obstetrics and gynecology.

[61]  A. Orr-Urtreger,et al.  Decreased first trimester PAPP‐A is a predictor of adverse pregnancy outcome , 2002, Prenatal diagnosis.

[62]  T. Ulahannan.  The Evidence Base of Clinical Diagnosis , 2002 .

[63]  H. Harrison.  Outcomes in young adulthood for very-low-birth-weight infants. , 2002, The New England journal of medicine.

[64]  K. Khan,et al.  Relationship between customised birthweight centiles and neonatal anthropometric features of growth restriction , 2002, BJOG : an international journal of obstetrics and gynaecology.

[65]  Gordon C. S. Smith,et al.  Early pregnancy levels of pregnancy-associated plasma protein a and the risk of intrauterine growth restriction, premature birth, preeclampsia, and stillbirth. , 2002, The Journal of clinical endocrinology and metabolism.

[66]  Y. Cheung,et al.  Size at birth and neonatal and postneonatal mortality , 2002, Acta paediatrica.

[67]  H. Honest,et al.  Reporting of measures of accuracy in systematic reviews of diagnostic literature , 2002, BMC health services research.

[68]  Theo Stijnen,et al.  Advanced methods in meta‐analysis: multivariate approach and meta‐regression , 2002, Statistics in medicine.

[69]  Alex J Sutton,et al.  Asymmetric funnel plots and publication bias in meta-analyses of diagnostic accuracy. , 2002, International journal of epidemiology.

[70]  S. Cicero,et al.  Screening for pre‐eclampsia and fetal growth restriction by uterine artery Doppler at 11–14 weeks of gestation , 2001, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[71]  S. Cnattingius,et al.  Perinatal outcome in SGA births defined by customised versus population‐based birthweight standards , 2001, BJOG : an international journal of obstetrics and gynaecology.

[72]  Jonathan J Deeks,et al.  Systematic reviews in health care: Systematic reviews of evaluations of diagnostic and screening tests. , 2001, BMJ.

[73]  B. Thilaganathan,et al.  Improved early prediction of pre‐eclampsia by combining second‐trimester maternal serum inhibin‐A and uterine artery Doppler , 2001, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[74]  J. Kleijnen,et al.  Systematic reviews to evaluate diagnostic tests. , 2001, European journal of obstetrics, gynecology, and reproductive biology.

[75]  T. Garite,et al.  Pregnancy outcome in Hispanic patients with unexplained positive triple marker screening for Down syndrome. , 2001 .

[76]  A. Heikkilä,et al.  Elevated Maternal Serum hCG in the Second Trimester Increases Prematurity Rate and Need for Neonatal Intensive Care in Primiparous Preeclamptic Pregnancies , 2001 .

[77]  Jean-Marie Moutquin,et al.  The Classification and Diagnosis of the Hypertensive Disorders of Pregnancy: Statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP) , 2001, Hypertension in pregnancy.

[78]  J. Moutquin,et al.  The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). , 2001 .

[79]  A. Heikkilä,et al.  Elevated maternal serum hCG in the second trimester increases prematurity rate and need for neonatal intensive care in primiparous preeclamptic pregnancies. , 2001, Hypertension in pregnancy.

[80]  H. Ishimoto,et al.  Prediction of Smallness for Gestational Age by Maternal Serum Human Chorionic Gonadotropin Levels and by Uterine Artery Doppler Study , 2000, Fetal Diagnosis and Therapy.

[81]  S. Hamdani,et al.  Intrauterine growth retardation , 2000 .

[82]  K. Nicolaides,et al.  First trimester maternal serum free β human chorionic gonadotrophin and pregnancy associated plasma protein A as predictors of pregnancy complications , 2000, BJOG : an international journal of obstetrics and gynaecology.

[83]  B. Sheu,et al.  Mid‐trimester β‐hCG levels incorporated in a multifactorial model for the prediction of severe pre‐eclampsia , 2000 .

[84]  W. Walters,et al.  Analysis of mid-trimester corticotrophin-releasing hormone and alpha-fetoprotein concentrations for predicting pre-eclampsia. , 2000, Human reproduction.

[85]  K. Harrington,et al.  Correlation between second trimester maternal serum inhibin-A and human chorionic gonadotrophin for the prediction of pre-eclampsia. , 2000, Placenta.

[86]  K. Nicolaides,et al.  Raised maternal serum inhibin A concentration at 10 to 14 weeks of gestation is associated with pre‐eclampsia , 2000, BJOG : an international journal of obstetrics and gynaecology.

[87]  J. Canick,et al.  Second-trimester levels of maternal serum human chorionic gonadotropin and inhibin a as predictors of preeclampsia in the third trimester of pregnancy. , 2000 .

[88]  J. Higgins,et al.  The detection, investigation and management of hypertension in pregnancy: full consensus statement , 2000, The Australian & New Zealand journal of obstetrics & gynaecology.

[89]  I. Olkin,et al.  Meta-analysis of observational studies in epidemiology - A proposal for reporting , 2000 .

[90]  S. Y. Kim,et al.  The prediction of adverse pregnancy outcome using low unconjugated estriol in the second trimester of pregnancy without risk of Down's syndrome. , 2000, Yonsei medical journal.

[91]  M. Morgan,et al.  Can antenatal clinical and biochemical markers predict the development of severe preeclampsia? , 2000, American journal of obstetrics and gynecology.

[92]  C. Rodeck,et al.  Serum screening for Down syndrome and adverse pregnancy outcomes: a case‐controlled study , 2000 .

[93]  J. Morris,et al.  Serum inhibin A and activin A are elevated prior to the onset of pre-eclampsia. , 2000, Human reproduction.

[94]  B. Haddad,et al.  Predictive value of early human chorionic gonadotrophin serum profiles for fetal growth retardation. , 1999, Human reproduction.

[95]  Y Yaron,et al.  Second-trimester maternal serum marker screening: maternal serum alpha-fetoprotein, beta-human chorionic gonadotropin, estriol, and their various combinations as predictors of pregnancy outcome. , 1999, American journal of obstetrics and gynecology.

[96]  S D Walter,et al.  Meta-analysis of diagnostic tests with imperfect reference standards. , 1999, Journal of clinical epidemiology.

[97]  P. Bossuyt,et al.  Empirical evidence of design-related bias in studies of diagnostic tests. , 1999, JAMA.

[98]  K. Leveno,et al.  Birth weight in relation to morbidity and mortality among newborn infants. , 1999, The New England journal of medicine.

[99]  M. Ryynänen,et al.  The effects on fetal development of high alpha-fetoprotein and maternal smoking. , 1999, American journal of public health.

[100]  J. Manson,et al.  Birthweight and the Risk for Type 2 Diabetes Mellitus in Adult Women , 1999, Annals of Internal Medicine.

[101]  U. Ekblad,et al.  Prediction of pre‐eclampsia with maternal mid‐trimester total renin, inhibin A, AFP and free β‐hCG levels , 1999, Prenatal diagnosis.

[102]  H. Gabert,et al.  Abnormal maternal serum alpha fetoprotein and pregnancy outcome. , 1998, The Journal of maternal-fetal medicine.

[103]  A. Hartikainen,et al.  Midtrimester N‐terminal Proatrial Natriuretic Peptide, Free Beta hCG, and Alpha‐fetoprotein in Predicting Preeclampsia , 1998, Obstetrics and gynecology.

[104]  J. Neilson,et al.  Second trimester serum free β human chorionic gonadotrophin levels as a predictor of pre‐eclampsia , 1998, Acta obstetricia et gynecologica Scandinavica.

[105]  L. Cusmano,et al.  Association of Low Unconjugated Estriol in the Second Trimester and Adverse Pregnancy Outcome , 1998, Obstetrics and gynecology.

[106]  L. Kornman,et al.  Maternal serum levels of free β‐hCG and PAPP‐A in the first trimester of pregnancy are not associated with subsequent fetal growth retardation or preterm delivery , 1998, Prenatal diagnosis.

[107]  A. Spinillo,et al.  A simultaneous evaluation of second trimester serum AFP, hCG and unconjugated oestriol as predictors of small for gestational age births , 1998 .

[108]  D. Barker,et al.  The long-term outcome of retarded fetal growth. , 1997, Clinical obstetrics and gynecology.

[109]  Khalid S. Khan,et al.  Seizure prophylaxis in hypertensive pregnancies: a framework for making clinical decisions , 1997, British journal of obstetrics and gynaecology.

[110]  K. Wenstrom,et al.  Pregnancy outcomes following false-positive multiple marker screening tests. , 1997, American journal of perinatology.

[111]  L. Morssink,et al.  The Association Between Hypertensive Disorders of Pregnancy and Abnormal Second‐Trimester Maternal Serum Levels of hCG and Alpha‐Fetoprotein , 1997, Obstetrics and gynecology.

[112]  W. Hay,et al.  Workshop summary: fetal growth: its regulation and disorders. , 1997, Pediatrics.

[113]  L. Önderoĝlu,et al.  Elevated second trimester human chorionic gonadotropin level associated withadverse pregnancy outcome , 1997, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[114]  M. de Onís,et al.  Effectiveness of interventions to prevent or treat impaired fetal growth. , 1997, Obstetrical & gynecological survey.

[115]  E. Lieberman,et al.  The value of elevated second-trimester beta-human chorionic gonadotropin in predicting development of preeclampsia. , 1997, American journal of obstetrics and gynecology.

[116]  B. A. Keel,et al.  Perinatal outcomes in a prospective matched pair study of pregnancy and unexplained elevated or low AFP screening , 1997, Journal of perinatal medicine.

[117]  H. Hoffman,et al.  Prediction of fetal growth based on maternal serum concentrations of human chorionic gonadotropin, human placental lactogen and estriol. , 1997, Acta obstetricia et gynecologica Scandinavica. Supplement.

[118]  E. Jauniaux,et al.  MATERNAL SERUM TESTING FOR ALPHA‐FETOPROTEIN AND HUMAN CHORIONIC GONADOTROPIN IN HIGH‐RISK PREGNANCIES , 1996, Prenatal diagnosis.

[119]  E. Hook,et al.  The Association Between Maternal Serum Alpha‐Fetoprotein and Preterm Birth, Small for Gestational Age Infants, Preeclampsia, and Placental Complications , 1996, Obstetrics and gynecology.

[120]  S. Saarikoski,et al.  Elevated midtrimester maternal serum hCG in chromosomally normal pregnancies is associated with preeclampsia and velamentous umbilical cord insertion. , 1996, American journal of perinatology.

[121]  L. Bussières,et al.  Maternal serum human chorionic gonadotropin level at fifteen weeks is a predictor for preeclampsia. , 1996, American journal of obstetrics and gynecology.

[122]  A. Milunsky,et al.  Maternal serum triple analyte screening and adverse pregnancy outcome. , 1996, Fetal diagnosis and therapy.

[123]  J. Rodis,et al.  Predicting pregnancy outcome from the degree of maternal serum alpha-fetoprotein elevation. , 1996, The Journal of reproductive medicine.

[124]  A. A. Akinbiyi.  Unexplained elevated maternal serum alpha‐fetoprotein in singleton pregnancies as a predictor of fetal risk , 1996, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[125]  R. O. Davis,et al.  Prognostic Significance of Unexplained Elevated Amniotic Fluid Alpha‐Fetoprotein , 1996, Obstetrics and gynecology.

[126]  J. Clive,et al.  Elevated Second‐Trimester Maternal Serum hCG Alone or in Combination With Elevated Alpha‐Fetoprotein , 1996, Obstetrics and gynecology.

[127]  A. Halligan,et al.  Lack of reproducibility in pregnancy of Korotkoff phase IV as measured by mercury sphygmomanometry , 1996, The Lancet.

[128]  Lisa A. Weissfeld,et al.  An assessment of the use of the continuity correction for sparse data in meta-analysis , 1996 .

[129]  J. Gondry,et al.  Validity in nulliparas of increased beta-human chorionic gonadotrophin at mid-term for predicting pregnancy-induced hypertension complicated with proteinuria and intrauterine growth retardation. , 1996, Nephron.

[130]  J. Haddow,et al.  Fetus-placenta-newborn☆ , 1995 .

[131]  L. Kornman,et al.  Abnormal levels of maternal serum human chorionic gonadotropin and alpha‐fetoprotein in the second trimester: Relation to fetal weight and preterm delivery , 1995, Prenatal diagnosis.

[132]  I. Bernstein,et al.  Uterine artery Doppler velocimetry in the detection of adverse obstetric outcomes in women with unexplained elevated maternal serum alpha-fetoprotein levels. , 1995, American journal of obstetrics and gynecology.

[133]  E. Pergament,et al.  Adverse pregnancy outcome after a false-positive screen for Down syndrome using multiple markers. , 1995, Obstetrics and gynecology.

[134]  J. Kingdom,et al.  [Unexplained increase in maternal plasma in alpha-fetoproteins in the second trimester of pregnancy: perinatal results]. , 1995, Revista chilena de obstetricia y ginecologia.

[135]  J. Haddow,et al.  Associations between adverse perinatal outcome and serially obtained second- and third-trimester maternal serum alpha-fetoprotein measurements. , 1995, American journal of obstetrics and gynecology.

[136]  D. Bloxam,et al.  Disturbed zinc metabolism and reduced birthweight related to raised maternal serum alpha‐fetoprotein in normal human pregnancies , 1994, Acta obstetricia et gynecologica Scandinavica.

[137]  R. Brian Haynes,et al.  Developing optimal search strategies for detecting clinically sound studies in MEDLINE. , 1994, Journal of the American Medical Informatics Association : JAMIA.

[138]  S. Grover,et al.  Unexplained elevated maternal serum alpha-fetoprotein levels and perinatal outcome in an urban clinic population. , 1994, American journal of obstetrics and gynecology.

[139]  J. Whitworth,et al.  Measuring blood pressure in pregnant women: a comparison of direct and indirect methods. , 1994, American journal of obstetrics and gynecology.

[140]  Frederick Mosteller,et al.  Guidelines for Meta-analyses Evaluating Diagnostic Tests , 1994, Annals of Internal Medicine.

[141]  G. Guyatt,et al.  Users' Guides to the Medical Literature: III. How to Use an Article About a Diagnostic Test: B. What Are the Results and Will They Help Me In Caring for My Patients? , 1994 .

[142]  G. Guyatt,et al.  Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group. , 1994, JAMA.

[143]  L. Shulman,et al.  Positive Serum Screening for Fetal Down Syndrome Does Not Predict Adverse Pregnancy Outcome in Absence of Fetal Aneuploidy , 1994, The Journal of the Society for Gynecologic Investigation: JSGI.

[144]  S. Nozawa,et al.  [Screening for adverse perinatal outcome by biomarkers in maternal serum; a comparison of elevated maternal serum alpha-fetoprotein versus human chorionic gonadotropin]. , 1994, Nihon Sanka Fujinka Gakkai zasshi.

[145]  H C Van Houwelingen,et al.  A bivariate approach to meta-analysis. , 1993, Statistics in medicine.

[146]  D. Luthy,et al.  Presented by invitation at the Fifty-ninth Annual Meeting of the Pacific Coast Obstetrical and Gynecological Society, Ojai, California, October 11-18, 1992. , 1993 .

[147]  D. Luthy,et al.  An association between elevated levels of human chorionic gonadotropin in the midtrimester and adverse pregnancy outcome. , 1993, American journal of obstetrics and gynecology.

[148]  G. Guyatt,et al.  Users' guides to the medical literature. , 1993, JAMA.

[149]  K. Wenstrom,et al.  Prediction of pregnancy outcome with single versus serial maternal serum alpha-fetoprotein tests. , 1992, American journal of obstetrics and gynecology.

[150]  M. Hayashi,et al.  [Clinical studies on maternal serum alpha-fetoprotein (MSAFP) of 532 cases--the median value, pregnancy outcomes and clinical evaluation]. , 1992, Nihon Sanka Fujinka Gakkai zasshi.

[151]  D. Nyberg,et al.  Elevated maternal serum alpha-fetoprotein levels and midtrimester placental abnormalities in relation to subsequent adverse pregnancy outcomes. , 1992, American journal of obstetrics and gynecology.

[152]  S. Bewley,et al.  Early prediction of uteroplacental complications of pregnancy using Doppler ultrasound, placental function tests and combination testing , 1992, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[153]  M. Sharf,et al.  The Association Between Unexplained Second- Trimester Maternal Serum hCG Elevation and Pregnancy Complications , 1992, Obstetrics and gynecology.

[154]  Capeless El,et al.  Elevated maternal serum alpha-fetoprotein levels and maternal risk factors. Their association with pregnancy complications. , 1992 .

[155]  R. Barth,et al.  Elevated Maternal Serum Alpha-Fetoprotein: Association With Placental Sonolucencies, Fetomaternal Hemorrhage, Vaginal Bleeding, and Pregnancy Outcome in the Absence of Fetal Anomalies , 1992, Obstetrics and gynecology.

[156]  E. Capeless,et al.  Elevated maternal serum alpha-fetoprotein levels and maternal risk factors. Their association with pregnancy complications. , 1992, The Journal of reproductive medicine.

[157]  Roop Ap,et al.  Study of the relationship between elevated maternal serum alpha-fetoprotein and adverse pregnancy outcome. , 1991 .

[158]  C. Weiner,et al.  Relationship Between Second Trimester Maternal Serum Alpha-Fetoprotein and Umbilical Artery Doppler Velocimetry and Their Association with Preterm Delivery , 1991, American journal of perinatology.

[159]  R. Fay,et al.  Ponderal Index: A Better Definition of the ‘At Risk’ Group With Intrauterine Growth Problems than Birth‐weight for Gestational Age in Term Infants , 1991, The Australian & New Zealand journal of obstetrics & gynaecology.

[160]  J. Boughman,et al.  Study of the relationship between elevated maternal serum alpha-fetoprotein and adverse pregnancy outcome. , 1991, Maryland medical journal.

[161]  P. Howie,et al.  Fetal growth achievement and neurodevelopmental disability , 1990 .

[162]  W. Willett,et al.  Predictive values, relative risks, and overall benefits of high and low maternal serum alpha‐fetoprotein screening in singleton pregnancies: New epidemiologic data , 1990, American journal of obstetrics and gynecology.

[163]  W. Willett,et al.  Predictive values, relative risks, and overall benefits of high and low maternal serum α-fetoprotein screening in singleton pregnancies: New epidemiologic data , 1989 .

[164]  D. Taylor,et al.  Fetal growth achievement and neurodevelopmental disability , 1989, British journal of obstetrics and gynaecology.

[165]  B. Burton.  Outcome of Pregnancy in Patients With Unexplained Elevated Or Low Levels of Maternal Serum Alpha-Fetoprotein , 1988, Obstetrics and gynecology.

[166]  L. Hagenfeldt,et al.  Outcome of pregnancy in relation to maternal serum alpha-fetoprotein levels in the second trimester. An evaluation of a screening program and a longitudinal follow-up. , 1988, Gynecologic and obstetric investigation.

[167]  G. Valentine,et al.  Maternal serum alpha-fetoprotein screening: report of a Canadian pilot project. , 1987, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[168]  J. Haddow,et al.  Can Low Birth Weight After Elevated Maternal Serum Alpha‐Fetoprotein Be Explained by Maternal Weight? , 1987, Obstetrics and gynecology.

[169]  R. C. Wood,et al.  Analysis of Birth Weight Percentile as a Predictor of Perinatal Outcome , 1986, Obstetrics and gynecology.

[170]  J. Haddow,et al.  Alpha‐fetoprotein, vaginal bleeding and pregnancy risk , 1986, British journal of obstetrics and gynaecology.

[171]  M. Tang,et al.  Justification of maternal serum alphafetoprotein screening in a population with low incidence of neural tube defects , 1986, Prenatal diagnosis.

[172]  T. Chard,et al.  Mid‐trimester levels of alphafetoprotein in the screening of low birthweight , 1986, British journal of obstetrics and gynaecology.

[173]  D. R. Aickin,et al.  Second Trimester Maternal Serum Alpha‐fetoprotein as an Indicator of Fetal Risk , 1985, The Australian & New Zealand journal of obstetrics & gynaecology.

[174]  J. Excler,et al.  Anthropometric assessment of nutritional status in newborn infants. Discriminative value of mid arm circumference and of skinfold thickness. , 1985, Early human development.

[175]  Whitfield Cr,et al.  Significance of raised maternal serum alpha-fetoprotein in singleton pregnancies with normally formed fetuses. , 1985 .

[176]  P. K. Hansen,et al.  High maternal serum alpha-fetoprotein and low birthweight. A study concerning possible correlation between maternal weight, smoking, and serum alpha-fetoprotein and subsequent birthweight and gestational age. , 1985, American journal of perinatology.

[177]  F. T. Mwambingu.  ASSOCIATION BETWEEN UNACCOUNTABLY HIGH MATERNAL ALPHA FETO‐PROTEIN AND INCREASED FETAL RISK , 1985 .

[178]  J. Grudzinskas,et al.  Placental protein measurements in complicated pregnancies. I. Intrauterine growth retardation , 1984, British journal of obstetrics and gynaecology.

[179]  J. Evans,et al.  Outcome of pregnancies associated with raised serum and normal amniotic fluid alpha fetoprotein concentrations. , 1984, British medical journal.

[180]  H. Thom,et al.  Maternal serum alpha-fetoprotein levels in low birth weight singleton pregnancies , 1984, Journal of perinatal medicine.

[181]  J. Haddow,et al.  Data from an Alpha‐Fetoprotein Pilot Screening Program in Maine , 1983, Obstetrics and gynecology.

[182]  N. Wald,et al.  MATERNAL SERUM ALPHA‐FETOPROTEIN AND BIRTH WEIGHT , 1980, British journal of obstetrics and gynaecology.

[183]  L. Barron,et al.  THE POTENTIAL OF MID‐TRIMESTER MATERNAL PLASMA ALPHA‐FETOPROTEIN MEASUREMENT IN PREDICTING INFANTS OF LOW BIRTH WEIGHT , 1980, British journal of obstetrics and gynaecology.

[184]  T. Chard,et al.  Maternal serum alpha-fetoprotein levels as an index of fetal risk. , 1979, American journal of obstetrics and gynecology.

[185]  B. Vohr,et al.  The preterm small-for-gestational age infant: a two-year follow-up study. , 1979, American journal of obstetrics and gynecology.

[186]  N. Wald,et al.  MATERNAL SERUM-ALPHA-FETOPROTEIN AND LOW BIRTH-WEIGHT , 1977, The Lancet.

[187]  R. Usher,et al.  Fetal malnutrition: its incidence, causes, and effects. , 1966, American journal of obstetrics and gynecology.